| Raloxifene hikes
bone density in women
The drug
raloxifene decreases the risk of broken vertebrae among postmenopausal
women.
References:
Ettinger, B., et
al. 1999. Reduction of vertebral fracture risk in postmenopausal
women with osteoporosis treated with raloxifene. Journal of the
American Medical Association 282(Aug. 18):637.
Further Readings:
Cummings, S.R., et
al. 1999. The effect of raloxifene on risk of breast cancer in
postmenopausal women. Journal of the American Medical Association
281(Aug. 18):2189.
Delmas, P.D., et
al. 1997. Effects of raloxifene on bone mineral density, serum
cholesterol concentrations, and uterine andometrium in postmenopausal
women. New England Journal of Medicine 337:1641.
McClung, M.R.
1999. Therapy for fracture prevention. Journal of the American
Medical Association 282(Aug. 18):687.
Seppa, N. 1999.
Raloxifene imparts anticancer benefit. Science News 155(June
19):388.
Sources:
Bruce Ettinger
Kaiser Permanente Medical Care Program
Division of Research
3505 Broadway, 13th Floor
Oakland, CA 94611-5400
From Science
News, Vol. 156, No. 10, September 4, 1999, p. 152. Copyright ©
1999, Science Service. |